Formulary Item Restrictions and/or Advice Site availability

Similar documents
Chapter 4 ~ Central nervous system

South London and the Maudsley NHS Foundation Trust Medicines Formulary

Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses

Mental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service

Medicines Formulary BNF Section 4 Central Nervous System

Antipsychotics. BMF 84 - Antipsychotics

SHARED CARE GUIDELINE

Document Title Antipsychotics Prescribing Guidelines for Schizophrenia

High Dose Antipsychotic Medication Policy

MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION

High Dose Antipsychotic Therapy (HDAT) guideline

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Joint Formulary for Psychotropic Medication.

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

Antipsychotic Prescribing Audit:

High Dose Antipsychotic Therapy (HDAT) guideline

Prescription of High Dose Antipsychotic Medication

This factsheet covers:

Antipsychotics. This factsheet covers -

Safe transfer of prescribing guidance

AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE

Treatment of Schizophrenia Appendix Three Page 1 of 8

NHS Grampian Guidance For Staff Working In The Mental Health Service For The Use Of High-Dose Antipsychotic Medication

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Formulary and Prescribing Guidelines

Medicines Guideline: High-dose antipsychotic prescribing (MG01)

Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Antipsychotic Medication: Monitoring Side Effects

FORMULARY AND PRESCRIBING GUIDELINES 2017

Guidelines on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]

National Clinical Audit of Psychosis (NCAP) Audit of practice form. Notes for completion

Birmingham and Solihull Mental Health NHS Foundation Trust. Formulary. March 2013

Thorazine 25 Mg Iv chlorpromazine hcl 50 mg chlorpromazine 10 mg chlorpromazine tablets uses chlorpromazine tablets ip 100mg thorazine ivpb

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly

GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA)

CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES?

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

University of Groningen. Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia

ANTIPSYCHOTIC GUIDELINES

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Guidance on the Use of Antipsychotics

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

National Center for Mental Health

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

DEPOT ANTIPSYCHOTIC MEDICATION: GUIDELINES FOR PRESCRIBING AND ADMINISTERING

National Center for Mental Health

List of changes in Out-Patients Formulary

MEDICINES FORMULARY JANUARY This version supersedes all previous versions for Medicines Formulary

New Medicines Committee Briefing November 2011

Scottish Medicines Consortium

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Bramley Health Formulary March 2016 Review Date March 2017

Antipsychotic Medications Age and Step Therapy

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds

FORMULARY AND PRESCRIBING GUIDANCE

THE STATE HOSPITALS BOARD FOR SCOTLAND ANNUAL REPORT. Medicines Committee. Reference Number

Resubmission. Scottish Medicines Consortium

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

Comparison of the Defined Daily Dose and Chlorpromazine Equivalent Methods in Antipsychotic Drug Utilization in Six Asian Countries

CLOZAPINE. Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent.

Physical health of those with serious mental illness.

Rapid Tranquillisation for adolescent, adults and older people Medicines management team July 2014

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011

Guidance on the Use of Antipsychotic Long-acting Injections in North of England

Table of Contents. 1.0 Policy Statement...1

Proposed Changes to Existing Measure for HEDIS : Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

See Important Reminder at the end of this policy for important regulatory and legal information.

Depot Antipsychotics

NSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.

Guidance on the Use of Antipsychotic Long-acting Injections in North of England (TEWV version)

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Antipsychotics in the treatment of schizophrenia

Clinical. High Dose Antipsychotic Prescribing Procedures. Document Control Summary. Contents

Rapid Tranquilisation Policy

Schizophrenia. Ajay Karia, Laura Kravitz and Chetan Shah

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

MEDICINES MANAGEMENT TOOL FOR ANTIPSYCHOTICS

Psychotropic Medication Utilization in Care Home Residents Age 65 or Older Compared with the Equivalent General Population in Scotland

Slide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts

Assessment of physical monitoring following rapid tranquillisation. Stephen Dye

PORT, 2009 Spain, 2009 Malaysia, 2009 Singapore, 2009 BAP, 2011 WFSBP, 2012 SIGN, 2013 Harvard NICE RANZCP, 2016

Schizophrenia in Greater Manchester: Audit

YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25

PULL OUT AND KEEP LEARNING SCENARIOS FOR THIS MODULE AT PHARMACY MAGAZINE

West London Mental Health NHS Trust Formulary

FORMULARY AND PRESCRIBING GUIDANCE

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Method. NeuRA First versus second generation antipsychotics August 2016

West London Mental Health NHS Trust Formulary

Transcription:

Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine 100mg/5ml syrup Chlorpromazine: If IM administration is necessary, haloperidol is preferred. Chlorpromazine is irritant and may cause hypotension and tachycardia BP should be monitored for 30 mins after IM. Not licensed for IV use; should not be used IV IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of Chlorpromazine 25mg/ml Flupentixol 3mg Haloperidol 500mcg capsule Haloperidol 1.5mg Haloperidol 5mg Haloperidol 10mg Haloperidol 2mg/ml liquid Haloperidol 5mg/ml IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of

Levomepromazine 25mg Levomepromazine 25mg/ml IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of Pimozide 4mg Prochlorperazine 5mg Prochlorperazine 5mg/5ml syrup Prochlorperazine 25mg suppository Prochlorperazine 12.5mg/ml Promazine 25mg Promazine 25mg/5ml oral solution Sulpiride 200mg Sulpiride 400mg Sulpiride 200mg/5ml SF oral suspension Trifluoperazine 1mg Trifluoperazine 5mg Trifluoperazine 5mg/5ml oral liquid Trifluoperazine 10mg SR capsule Trifluoperazine 15mg SR capsule IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of

Zuclopenthixol dihydrochloride 10mg Zuclopenthixol dihydrochloride 25mg Zuclopenthixol acetate 50mg/ml Zuclopenthixol acetate 100mg/2ml (Clopixol Acuphase ) Atypical Antipsychotics Amisulpride 50mg Amisulpride 200mg Amisulpride 400mg Amisulpride 100mg/ml solution Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of

Aripiprazole 5mg Aripiprazole 10mg Aripiprazole 10mg orodispersible Aripiprazole 15mg Aripiprazole 15mg orodispersible Aripiprazole 7.5mg/ml (1.3-ml (9.75- mg) vial) Clozapine 25mg Clozapine 100mg (Zaponex ) Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of Registration with the Zaponex Treatment Access System (Ztas) and routine blood counts are required due to the risk of agranulocytosis

Olanzapine 2.5mg Olanzapine 5mg Olanzapine 7.5mg Olanzapine 10mg Olanzapine 15mg Olanzapine 20mg Olanzapine 5mg orodispersible Olanzapine 10mg orodispersible Olanzapine 15mg orodispersible Olanzapine 20mg orodispersible Olanzapine 10mg Quetiapine 25mg Quetiapine 100mg Quetiapine 150mg Quetiapine 200mg Quetiapine 300mg Quetiapine 50mg M/R Quetiapine 200mg M/R Quetiapine 300mg M/R Quetiapine 400mg M/R Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of IM doses are lower than equivalent There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of

Risperidone 500mcg Risperidone 1mg Risperidone 2mg Risperidone 3mg Risperidone 4mg Risperidone 6mg Risperidone 3mg orodispersible Risperidone 4mg orodispersible Risperidone 1mg/ml liquid Risperidone 1mg orodispersible Risperidone 2mg orodispersible Atypical antipsychotics: Extrapyramidal symptoms and No evidence supporting use in No evidence supporting prn use of There is no convincing evidence that Approximate equivalent doses of Advice of Royal College of chlorpromazine/day) see BNF Antipsychotic depot s - typicals 20mg/ml 100mg/ml 200mg/ml 40mg/2ml 50mg/0.5ml 100mg/ml 25mg/ml 12.5mg/0.5ml 50mg/0.5ml Haloperidol decanoate 50mg/ml Haloperidol decanoate 100mg/ml Pipotiazine palmitate 50mg/ml Pipotiazine palmitate 100mg/2ml

Zuclopenthixol decanoate 200mg/ml Zuclopenthixol decanoate 500mg/ml Antipsychotic depot s - atypicals Risperidone 25mg depot Risperidone 37.5mg depot Risperidone 50mg Antimanic drugs Valproic acid 250mg EC Lithium carbonate 200mg SR Lithium carbonate 250mg Lithium carbonate 400mg MR Lithium citrate (Li-Liquid) 509mg/5ml Lithium citrate (Priadel) 520mg/5ml Mental Health Trust Only Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment Note: Lithium carbonate 200mg lithium citrate 509mg